Real-time disaster intelligence, alerts, and response tools.
Saturday, March 7, 2026
[ad_1] TAIPEI and SAN DIEGO, Dec. 10, 2025 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company developing first-in-class therapies for difficult-to-treat cancers, today announced a clinical supply agreement with BeOne Medicines, a global […]
[ad_1] – Data reflect new insights and precision oncology advancements in portfolio and pipeline – – Cohort results from Phase 2 ILUSTRO study evaluating a zolbetuximab triplet combination regimen in first-line advanced gastric and gastroesophageal […]
[ad_1] Company receives the highest Water Security rating in two years into participation Recognized for exceptional leadership in environmental stewardship INCHEON, South Korea, Dec. 10, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a leading contract development […]
[ad_1] Key Highlights: First-in-human milestone: The inaugural patient has been dosed with PRV131. Precise, localized delivery: Built on Privo’s PRV Platform technology, PRV131 delivers high concentrations of cisplatin directly to tumors, while minimizing systemic exposure. […]
[ad_1] Lemon Verbena-Hibiscus Supports Weight Goals Through Body and Mind Key takeaways US-based consumer study suggests Metabolaid® exerts a positive impact on weight management, motivation, and emotional stability. Participants show reduction in weight over 8-week assessment, […]
